Predictively consistent prior effective sample sizes.

Biometrics
Beat NeuenschwanderAnthony O'Hagan

Abstract

Determining the sample size of an experiment can be challenging, even more so when incorporating external information via a prior distribution. Such information is increasingly used to reduce the size of the control group in randomized clinical trials. Knowing the amount of prior information, expressed as an equivalent prior effective sample size (ESS), clearly facilitates trial designs. Various methods to obtain a prior's ESS have been proposed recently. They have been justified by the fact that they give the standard ESS for one-parameter exponential families. However, despite being based on similar information-based metrics, they may lead to surprisingly different ESS for nonconjugate settings, which complicates many designs with prior information. We show that current methods fail a basic predictive consistency criterion, which requires the expected posterior-predictive ESS for a sample of size N to be the sum of the prior ESS and N. The expected local-information-ratio ESS is introduced and shown to be predictively consistent. It corrects the ESS of current methods, as shown for normally distributed data with a heavy-tailed Student-t prior and exponential data with a generalized Gamma prior. Finally, two applications are d...Continue Reading

References

Mar 1, 1976·Journal of Chronic Diseases·S J Pocock
Feb 15, 2003·Statistics in Medicine·Peter F ThallRobert S Benjamin
Nov 12, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Steven N Goodman, John T Sladky
Sep 4, 2007·Biometrics·Satoshi MoritaPeter Müller
Dec 29, 2007·Journal of Biopharmaceutical Statistics·Gene Pennello, Laura Thompson
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rashmi ChughLaurence H Baker
Sep 8, 2009·Statistics in Medicine·Beat NeuenschwanderDavid J Spiegelhalter
Feb 17, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Beat NeuenschwanderDavid J Spiegelhalter
Nov 2, 2011·Biometrics·L G Leon-NoveloK Wathen
Sep 1, 2012·Bayesian Analysis·Satoshi MoritaPeter Müller
Sep 3, 2014·Clinical Trials : Journal of the Society for Clinical Trials·Peter F ThallJ Clift Norris
Dec 20, 2015·Pharmaceutical Statistics·Beat NeuenschwanderStuart Bailey
Jan 1, 2015·Therapeutic Innovation & Regulatory Science·Roland FischHeinz Schmidli
Feb 2, 2019·British Journal of Clinical Pharmacology·Cécile OllivierRobert Hemmings
Mar 3, 2020·Clinical Trials : Journal of the Society for Clinical Trials·Emily Han-Chung HsiueG Caleb Alexander
Apr 8, 2020·The Journal of Sexual Medicine·James A Simon, Meredith D Kapner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.